Literature DB >> 7889978

Potential inhibition of alkylating agent metabolism by fluconazole.

S M Yule, D Walker, A D Pearson, J R Idle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7889978     DOI： 10.1007/bf02111837

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

1.  Interaction of fluconazole and cyclosporine.

Authors:  A M Sugar; C Saunders; B A Idelson; D B Bernard
Journal:  Ann Intern Med       Date:  1989-05-15       Impact factor: 25.391

Review 2.  Metabolism of oxazaphosphorines.

Authors:  N E Sladek
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

3.  Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

Authors:  T Kronbach; V Fischer; U A Meyer
Journal:  Clin Pharmacol Ther       Date:  1988-06       Impact factor: 6.875

4.  Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide.

Authors:  D Walker; J P Flinois; S C Monkman; C Beloc; A V Boddy; S Cholerton; A K Daly; M J Lind; A D Pearson; P H Beaune
Journal:  Biochem Pharmacol       Date:  1994-03-29       Impact factor: 5.858

5.  A simple non-invasive procedure for the investigation of cytochrome P-450 IIIA dependent enzymes in humans.

Authors:  T Bienvenu; E Rey; G Pons; P d'Athis; G Olive
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1991-11

6.  Fluconazole: a potent inhibitor of cytochrome P-450-dependent drug-metabolism in mice and humans in vivo. Comparative study with ketoconazole.

Authors:  K Morita; H Konishi; H Shimakawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1992-05       Impact factor: 1.645

7.  A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group.

Authors:  J Ninane
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-04       Impact factor: 3.267

8.  Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.

Authors:  T K Chang; G F Weber; C L Crespi; D J Waxman
Journal:  Cancer Res       Date:  1993-12-01       Impact factor: 12.701
  8 in total
  1 in total

Review 1.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.